购物车
- 全部删除
- 您的购物车当前为空
TSHR antagonist S37a is a selective antagonist of thyrotropin receptor (TSHR), with potential for the treatment of Graves' orbitopathy.
TSHR antagonist S37a is a selective antagonist of thyrotropin receptor (TSHR), with potential for the treatment of Graves' orbitopathy.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 3,420 | 5日内发货 | |
5 mg | ¥ 3,990 | 5日内发货 | |
10 mg | ¥ 6,650 | 5日内发货 | |
1 mL x 10 mM (in DMSO) | ¥ 3,960 | 5日内发货 |
产品描述 | TSHR antagonist S37a is a selective antagonist of thyrotropin receptor (TSHR), with potential for the treatment of Graves' orbitopathy. |
体外活性 | In HEK293 cells, TSHR antagonist S37a is an inhibitor of TSHR(IC50s of 40 μM and approximately 20 μM for mTSHR and hTSHR, respectively). TSHR antagonist S37a also activation by monoclonal TSAb M22 (human), KSAb1 (murine), and the allosteric small-molecule agonist C2. |
体内活性 | In GO patients' sera, TSHR antagonist S37a inhibits cyclic adenosine monophosphate formation by oligoclonal TSAb, which are highly enriched. |
分子量 | 460.57 |
分子式 | C25H20N2O3S2 |
CAS No. | 2143452-20-2 |
密度 | 1.54 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容